IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma

被引：12

作者：

Wang, Zewei ^{[1
]}

Xu, Le ^{[2
]}

Chang, Yuan ^{[3
]}

Zhou, Lin ^{[3
]}

Fu, Hangcheng ^{[1
]}

Zhang, Weijuan ^{[4
]}

Yang, Yuanfeng ^{[3
]}

Xu, Jiejie ^{[1
]}

机构：

[1] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai, Peoples R China

[3] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China

[4] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China

来源：

TUMOR BIOLOGY | 2016年 / 37卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Clear-cell renal cell carcinoma; Interleukin-33; Prognostic biomarker; Overall survival; ACQUIRED-IMMUNITY; CANCER; EXPRESSION; INNATE; ST2; INTERLEUKIN-33; CONTRIBUTES; MACROPHAGES; CYTOKINE; PATHWAY;

D O I：

10.1007/s13277-016-4879-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The aim of this study was to evaluate the potential prognostic significance of interleukin-33 (IL-33) in patients with clear-cell renal cell carcinoma (ccRCC) after surgical resection. In this retrospective research, we enrolled 203 patients with ccRCC undergoing nephrectomy between 2003 and 2004 in a single institution. We recorded clinicopathologic features, overall survival (OS), and recurrence-free survival (RFS) and assessed IL-33 expression by immunohistochemical staining. On such bases, the correlations between IL-33 expression and clinicopathologic features and prognosis were evaluated. A high expression of IL-33 was significantly associated with advanced TNM stage and Fuhrman grade (p = 0.017 and p < 0.001, respectively) in patients with ccRCC. Moreover, multivariate analysis identified IL-33 as an independent prognostic factor of OS for patients with ccRCC after surgery (hazard ratio = 2.050; 95 % CI 1.223-3.447; p = 0.006). The incorporation of IL-33 into the TNM stage and Fuhrman grade might help to refine individual risk stratification. The IL-33 expression may serve as an independent negative predictor of survival for patients with ccRCC after surgery.

引用

页码：11127 / 11134

页数：8

共 50 条

[21] Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma [J].

Chang, Y. ;

An, H. ;

Xu, L. ;

Zhu, Y. ;

Yang, Y. ;

Lin, Z. ;

Xu, J. .

BRITISH JOURNAL OF CANCER, 2015, 113 (04) :626-633

[22] Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients [J].

Lian, Meiqin ;

Feng, Yueyuan ;

Wu, Zhenyu ;

Zheng, Zhonghong ;

Liu, Huanhuan ;

Li, Jian ;

Yu, Huixia ;

Lian, Changlin .

MEDICINE, 2023, 102 (31) :E34582

[23] Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma [J].

Chang, Yuan ;

Xu, Le ;

Zhou, Lin ;

Fu, Qiang ;

Liu, Zheng ;

Yang, Yuanfeng ;

Lin, Zongming ;

Xu, Jiejie .

ONCOTARGET, 2016, 7 (17) :24527-24536

[24] Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas [J].

Cui, Guanglin ;

Ren, Jingli ;

Xu, Gang ;

Li, Zhenfeng ;

Zheng, Wei ;

Yuan, Aping .

CANCER CELL INTERNATIONAL, 2018, 18

[25] High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma [J].

Na, Ning ;

Li, Heng ;

Xu, Chengfang ;

Miao, Bin ;

Hong, Liangqing ;

Huang, Zhengyu ;

Jiang, Qiu .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :279-285

[26] Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma [J].

Xiong, Ying ;

Liu, Li ;

Xia, Yu ;

Wang, Jiajun ;

Xi, Wei ;

Bai, Qi ;

Qu, Yang ;

Xu, Jiejie ;

Guo, Jianming .

BMC CANCER, 2017, 17

[27] High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma [J].

Xiong, Ying ;

Liu, Li ;

Xia, Yu ;

Wang, Jiajun ;

Xi, Wei ;

Bai, Qi ;

Qu, Yang ;

Long, Qilai ;

Xu, Jiejie ;

Guo, Jianming .

ONCOTARGET, 2016, 7 (39) :63661-63668

[28] Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma [J].

Ying Xiong ;

Li Liu ;

Yu Xia ;

Jiajun Wang ;

Wei Xi ;

Qi Bai ;

Yang Qu ;

Jiejie Xu ;

Jianming Guo .

BMC Cancer, 17

[29] Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma [J].

Pingcuo Laba ;

Jianfeng Wang ;

Jin Zhang .

BMC Cancer, 18

[30] Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma [J].

Palumbo, Carlotta ;

Mistretta, Francesco A. ;

Knipper, Sophie ;

Pecoraro, Angela ;

Tian, Zhe ;

Dzyuba-Negrean, Cristina ;

Shariat, Shahrokh F. ;

Saad, Fred ;

Simeone, Claudio ;

Berruti, Alfredo ;

Briganti, Alberto ;

Kapoor, Anil ;

Antonelli, Alessandro ;

Karakiewicz, Pierre I. .

CLINICAL GENITOURINARY CANCER, 2020, 18 (06) :E730-E738

← 1 2 3 4 5 →